10:16 EST Kerrisdale Capital says short Altimmune, says only drug ‘going to bomb’
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALT:
- Altimmune call volume above normal and directionally bullish
- Altimmune reinstated with a Neutral at Goldman Sachs
- Unusually active option classes on open January 10th
- The biotech stocks to own in 2024, according to Piper Sandler
- Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024